ResMed | RMD - 应收帐款人



金融业
股票价格
USD
资产
USD 8.78B
现金及等价物
USD 1.66B
销售成本
USD 551.67M
流动资产
USD 4.06B
流动负债
USD 1.35B
债务
USD 847.72M
股息收益率
1.04
EBIT
USD 505.67M
EBITDA
USD 547.48M
员工
10.6K
EPS每股收益
USD 2.86
股本和储备
USD 6.49B
销售毛利
USD 890.98M
债务利息支出
USD 8.79M
利息收入
USD 59K
贷款资金
USD 404.17M
市值
USD 30.6B
净收入
USD 398.73M
营业费用
USD 925.74M
营业利润
USD 505.67M
普通股股本
USD 190.83M
PE价格收益
21.21
税前利润
USD 496.15M
销售收入
USD 1.4B
销售和管理费用
USD 279.8M
股票
USD 911.88M
贸易债权人
USD 273.3M
应收帐款人
USD 998.84M


应收帐款人 更改 日
Ansell USD 231.1M 15.4M 2025-12
Artivion USD 103.68M 6.31M 2025-12
AtriCure USD 71.31M 4.66M 2026-03
Baxter International USD 1.7B 310M 2026-03
Cochlear AUD 568.4M 17.5M 2025-12
Cooper Companies USD 807.1M 21.9M 2025-12
CSL USD 4.32B 1.35B 2025-12
Dexcom USD 1.09B 182.1M 2026-03
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Fisher Paykel Healthcare NZD 335.7M 16.5M 2025-12
Globus Medical USD 735.44M 8.23M 2026-03
Haemonetics USD 195.71M 11.36M 2025-12
Idexx Laboratories USD 697.21M 144.83M 2026-03
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 544.7M 27.8M 2026-03
Integra LifeSciences USD 264.41M 14.44M 2026-03
Intuitive Surgical USD 1.6B 68.3M 2026-03
Masimo USD 288.9M 103M 2026-03
Medtronic USD 6.36B 30M 2025-12
Philips EUR 3.53B 273M 2026-03
Ramsay Health Care AUD 2.48B 22.3M 2025-12
ResMed USD 998.84M 13.2M 2026-03
Sigma Healthcare AUD 2.56B 2.23B 2025-12
Sonic Healthcare AUD 1.39B 23.76M 2024-12
Steris USD 1.09B 102.2M 2026-03
Teleflex USD 365.53M 19.94M 2026-03
Thermo Fisher Scientific USD 9.2B 304M 2026-03